Skip to main content

Table 1 Patient’s characteristic

From: Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2 V617F allelic burden

  PegIFNα (n = 25) Hydroxyurea (n = 7)
Age 57.0 64
Median (range) (39–86) (61–77)
Gender
Male/female 14/12 5/2
Diagnosis
PV/ET/ET-MF 18/7/1 5/1/1
JAK2 V617F allelic burden 25.4 60
Median (range) (1.0–99.2) (4.54–93.3)
Hematocrit  % 46.9 50.5
Median (range) (28.7–70) (33.4–70.2)
WBC ×109/L 8.1 8.0
Median (range) (2.5–17.3) (4.3–12.5)
Platelets × 109/L 391 393
Median (range) (112–1555) (123–878)